These overall results suggest that the induction of multiple antigen-targeting CD8 T-cells and sufficient endurance of PD-L1 blockade amplified intensely the therapeutic effectiveness of DC_TriVax regimen towards clonally heterogeneous C1498 myeloid leukaemia. Here, CD274 is linked to myeloid leukemia.